New Nordic Healthbrands AB (NNH) AI Stock Analysis

New Nordic Healthbrands AB

(Nasdaq OMX AB:NNH)

Select Model

Rating:58Neutral

Price Target:SEK 15.50▲(6.53% Upside)

Action:reiterated

Date:10/31/26

The score is supported primarily by improving profitability, a manageable balance sheet and reasonable valuation. These positives are outweighed by thin margins, uneven cash generation and clearly weak technical momentum, resulting in a below-average overall stock score.

Positive Factors

Return to profitability and revenue growthThe return to positive EBIT and net income, alongside 3.68% revenue growth, indicates that the business has regained operating traction. Continued top-line expansion and profitability would improve internal funding capacity and support stronger performance over the next several quarters.

Negative Factors

Thin profit marginsVery thin net and EBIT margins leave limited room for adverse changes in costs, pricing, or product mix before profitability is impaired. This makes earnings less resilient and means relatively modest operating pressure could materially reduce returns over the coming quarters.

New Nordic Healthbrands AB (NNH) vs. iShares MSCI Sweden ETF (EWD)

Market Cap: SEK 90.14M
Dividend Yield: 1.72%
Average Volume (3M): 10.10K
Price to Earnings (P/E): 11.5
Beta (1Y): 0.35
Revenue Growth: 2.70%
EPS Growth: -43.94%
Country: Sweden
Employees: 81
Sector: General
Sector Strength: 55
Industry: Packaged Foods

New Nordic Healthbrands AB Business Overview & Revenue Model

Company Description

New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vitali...

How the Company Makes Money

NNH primarily makes money by selling branded health and wellness products (mainly dietary supplements/nutraceuticals) to distribution channels that then sell to end consumers. Revenue is generated through (1) wholesale/B2B sales to retailers, pharmac...

New Nordic Healthbrands AB Financial Statement Overview

Summary

Profitability has returned after several loss-making years, and the balance sheet is relatively sound with moderate leverage. However, margins remain thin and cash flow has been historically volatile, limiting the strength of the recovery.

Income Statement

63Positive

Balance Sheet

71Positive

Cash Flow

58Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	585.81M	576.36M	550.31M	533.85M	487.50M	514.85M
Gross Profit	98.15M	15.95M	354.69M	348.23M	318.50M	350.05M
EBITDA	16.58M	17.61M	-2.42M	-1.27M	-2.00M	29.48M
Net Income	7.84M	8.20M	-7.70M	-6.19M	-2.82M	21.30M
Balance Sheet
Total Assets	292.50M	246.15M	248.72M	249.06M	251.67M	238.35M
Cash, Cash Equivalents and Short-Term Investments	9.91M	16.55M	15.25M	13.81M	10.70M	11.88M
Total Debt	37.06M	35.84M	39.22M	26.64M	48.35M	24.43M
Total Liabilities	183.84M	142.69M	148.19M	143.03M	139.10M	118.03M
Stockholders Equity	108.65M	103.47M	100.92M	106.03M	112.57M	120.32M
Cash Flow
Free Cash Flow	5.21M	7.57M	-6.62M	25.88M	-18.41M	-10.58M
Operating Cash Flow	5.57M	8.39M	-5.40M	28.03M	-15.45M	-7.87M
Investing Cash Flow	-3.16M	-3.22M	-3.71M	-3.40M	-2.62M	-2.97M
Financing Cash Flow	-2.24M	-3.38M	10.39M	-21.17M	16.59M	12.07M

New Nordic Healthbrands AB Technical Analysis

Technical Analysis SentimentNegative

Last Price14.55

Price Trends

50DMA17.55Negative

100DMA16.05Negative

200DMA16.44Negative

Market Momentum

MACD-0.29Positive

RSI26.43Positive

STOCH37.40Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Negative. The current price of 14.55 is below the 20-day moving average (MA) of 17.89, below the 50-day MA of 17.55, and below the 200-day MA of 16.44, indicating a bearish trend. The MACD of -0.29 indicates Positive momentum. The RSI at 26.43 is Positive, neither overbought nor oversold. The STOCH value of 37.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NNH.

New Nordic Healthbrands AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

SE:NNH against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:GENI	91Outperform	SEK 456.03M	14.81	―	4.58%	6.76%	1.88%
SE:ZZ.B	85Outperform	SEK 5.44B	11.84	48.04%	4.45%	32.85%	101.50%
SE:MSON.B	67Neutral	SEK 1.38B	8.49	5.43%	2.27%	-1.42%	―
SE:NNH	58Neutral	SEK 93.24M	11.46	―	1.72%	2.70%	-43.94%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SE:ENZY	44Neutral	SEK 551.01M	-13.75	―	―	-2.36%	23.44%
SE:ARCTIC	41Neutral	SEK 11.40M	-0.75	―	―	-21.49%	69.53%

* General Sector Average

Performance Comparison

SE:NNH and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SE:NNH	New Nordic Healthbrands AB	14.55	-9.16	-38.64%
SE:ZZ.B	Zinzino AB Class B	134.90	25.13	22.89%
SE:MSON.B	Midsona AB Class B	9.68	1.74	21.93%
SE:ARCTIC	Arctic Blue Beverages AB	0.13	-0.05	-26.92%
SE:ENZY	Enzymatica AB	2.30	0.36	18.56%
SE:GENI	Generic Sweden AB	38.20	-6.81	-15.13%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026

New Nordic Healthbrands AB AI Stock Analysis